The antidepressant-like effect of ethynyl estradiol is mediated by both serotonergic and noradrenergic systems in the forced swimming test

Neuroscience

Volumn 250, Issue , 2013, Pages 102-111

  Vega Rivera, N M ^a,b   Lopez Rubalcava C ^b   Estrada Camarena, E ^a  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Estrogen receptors; Ethynyl estradiol; Forced swimming test; Noradrenaline; Presynaptic sites; Serotonin

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; 5,7 DIHYDROXYTRYPTAMINE; ALPHA 2 ADRENERGIC RECEPTOR; ESTROGEN RECEPTOR; ETHINYLESTRADIOL; FULVESTRANT; IDAZOXAN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FEMALE; FORCED SWIMMING TEST; FRONTAL CORTEX; HIPPOCAMPUS; IMMOBILIZATION; NONHUMAN; NORADRENERGIC SYSTEM; OUTCOME ASSESSMENT; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

17Α-ETHYNYL-ESTRADIOL; 5,7-DHT; 5,7-DIHYDROXYTRYPTAMINE; ANALYSIS OF VARIANCE; ANOVA; DA; DOPAMINE; DSP(4); EDTA; EE(2); ERS; ESTROGEN RECEPTORS; ETHYLENEDIAMINETETRAACETIC ACID; ETHYNYL-ESTRADIOL; FORCED SWIMMING TEST; FST; HIGH-PRESSURE LIQUID CHROMATOGRAPHY; HPLC; N-(2-CHLORO-ETHYL)-N-ETHYL-2-BROMOBENZYLAMINE; NA; NORADRENALINE; OVARIECTOMY; OVX; PRESYNAPTIC SITES; SELECTIVE SEROTONIN REUPTAKE INHIBITOR; SEROTONIN; SSRI;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN CHEMISTRY; CATECHOLAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESTRADIOL; ESTROGEN ANTAGONISTS; ETHINYL ESTRADIOL; FEMALE; IDAZOXAN; INJECTIONS, INTRAVENTRICULAR; MOTOR ACTIVITY; NOREPINEPHRINE; RATS; SEROTONIN; STEREOTAXIC TECHNIQUES; SWIMMING;

EID: 84881105270     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.06.058     Document Type: Article

References (70)

1. Altman S.E., Shankmana S.A., Springb B. Effect of acute tryptophan depletion on emotions in individuals with personal and family history of depression following a mood induction. Neuropsychobiology 2010, 62:171-176.
2. Baumgarten H.G., Björklund A. Neurotoxic indoleamines and monoamine neurons. Annu Rev Pharmacol Toxicol 1976, 16:101-111. [review].
3. Berman R.M., Sanacora G., Anand A., Roach L.M., Fasula M.K., Finkelstein C.O., Wachen R.M., Oren D.A., Heninger G.R., Charney D.S. Monoamine depletion in unmedicated depressed subjects. Biol Psychiatry 2002, 51:469-473.
4. Bjorklund A., Baumgarten H.G., Lachenmayer L., Rosengren E. Recovery of brain noradrenaline after 5,7-dihydroxytryptamine-induced axonal lesions in the rat. Cell Tissue Res 1975, 161:145-155.
5. Carlberg K.A., Fregly M.J. Catecholamine excretion and beta-adrenergic responsiveness in estrogen-treated rats. Pharmacology 1986, 32:147-156.
6. Carr G., Lucki I. The role of serotonin receptor subtypes in treating depression: a review of animal studies. Psychopharmacology (Berl) 2011, 213:265-287.
7. Carrasco G.A., Barker S.A., Zhang Y., Damjanoska K.J., Sullivan N.R., Garcia F., D'souza D.N., Muma N.A., van De Kar L.D. Estrogen treatment increases the levels of regulator of G protein signaling-Z1 in the hypothalamic paraventricular nucleus: possible role in desensitization of 5-hydroxytryptamine1A receptors. Neuroscience 2004, 127:261-267.
8. Dailly E., Chenu F., Petit-Demouliére B., Bourin M. Specificity and efficacy of noradrenaline, serotonin depletion in discrete brain areas of Swiss mice by neurotoxins. J Neurosci Methods 2006, 150:111-115.
9. Brezun J.M., Daszuta A. Depletion in Serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats. Neuroscience 1999, 89:999-1002.
10. Delgado P.L. Depression: the case for a monoamine deficiency. J Clin Psychiatry 2000, 61(Suppl. 6):7-11.
11. Delgado P.L., Charney D.S., Price L.H., Aghajanian G.K., Landis H., Heninger G.R. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990, 47:411-418.
12. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 1995, 121:66-72.
13. Donner N., Handa R.J. Estrogen receptor beta regulates the expression of tryptophan-hydroxylase 2 mRNA within serotonergic neurons of the rat dorsal raphe nuclei. Neuroscience 2009, 163:705-718.
14. Dören M., Nilsson J.-A., Johnell O. Effects of specific post-menopausal hormone therapies on bone mineral density in post-menopausal women: a meta-analysis. Hum Reprod 2003, 18:1737-1746.
15. Espejo E.F., Minano F.J. Prefrontocortical dopamine depletion induces antidepressant-like effects in rats and alters the profile of desipramine during Porsolt's test. Neuroscience 1999, 88:609-615.
16. Esteban S., Lladó J., García-Sevilla J.A. Alpha 2-autoreceptors and alpha 2-heteroreceptors modulating tyrosine and tryptophan hydroxylase activity in the rat brain in vivo: an investigation into the alpha 2-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol 1996, 353:391-399.
17. Esteban S., Lladó J., Sastre-Coll A., García-Sevilla J.A. Activation and desensitization by cyclic antidepressant drugs of alpha2-autoreceptors, alpha2-heteroreceptors and 5-HT1A-autoreceptors regulating monamine synthesis in the rat brain in vivo. Naunyn Schmiedebergs Arch Pharmacol. 1999, 360:135-143.
18. Estrada-Camarena E., Fernández-Guasti A., López-Rubalcava C. Antidepressant-like effect of different estrogenic compounds in the forced swimming test. Neuropsychopharmacology 2003, 28:830-838.
19. Estrada-Camarena E., Fernández-Guasti A., López-Rubalcava C. Interaction between estrogens and antidepressants in the forced swimming test in rats. Psychopharmacology (Berl) 2004, 173:139-145.
20. Estrada-Camarena E., Lopez-Rubalcava C., Hernandez-Aragon A., Mejia-Mauries S., Picazo O. Long-term ovariectomy modulates the antidepressant-like action of estrogens, but not of antidepressants. J Psychopharmacol 2011, 25:1365-1377.
21. Fernández-Guasti A., Roldán-Roldán G., Larsson K. Anxiolytics reverse the acceleration of ejaculation resulting from enforced intercopulatory intervals in rats. Behav Neurosci 1991, 105:230-240.
22. Fernández-Guasti A., Ferreira A., Picazo O. Diazepam, but not buspirone, induces similar anxiolytic-like actions in lactating and ovariectomized Wistar rats. Pharmacol Biochem Behav 2001, 70:85-93.
23. Filardo E., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000, 14:1649-1660.
24. Firk C., Markus R. Effects of acute tryptophan depletion on affective processing in first-degree relatives of depressive patients and controls after exposure to uncontrollable stress. Psychopharmacology 2008, 199:151-160.
25. Fritschy J.M., Grzanna R. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals. Neuroscience 1989, 30:181-197.
26. Frye C.A., Rhodes M.E. Enhancing effects of estrogen on inhibitory avoidance performance may be in part independent of intracellular estrogen receptors in the hippocampus. Brain Res 2002, 956:285-293.
27. Ghraf R., Michel M., Hiemke C., Knuppen R. Competition by monophenolic estrogens and catecholestrogens for high-affinity uptake of [3H](-)-norepinephrine into synaptosomes from rat cerebral cortex and hypothalamus. Brain Res 1983, 277:163-168.
28. Gobbi M., Regondi M.C., Pompeiano M., Palacios J.M., Mennini T. Differential effects of 5,7-dihydroxytryptamine-induced serotoninergic degeneration of 5-HT1A receptors and 5-HT uptake sites in the rat brain. J Chem Neuroanat 1994, 7:65-73.
29. Gobert A., Rivet J.M., Audinot V., Newman-Tancredi A., Cistarelli L., Millan M.J. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release. Neuroscience 1998, 84:413-429.
30. Hensler J.G., Kovachich G.B., Frazer A. A quantitative autoradiographic study of serotonin1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 1991, 4:131-144.
31. Howell A. Pure oestrogen antagonists for the treatment of advanced breast cancer. Endocr Relat Cancer 2006, 13:689-706.
32. 4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine) - a useful denervation tool for central and peripheral noradrenaline neurons. Eur J Pharmacol 1981, 72:173-188.
33. Karkanias G.B., Li C.S., Etgen A.M. Estradiol reduction of alpha 2-adrenoceptor binding in female rat cortex is correlated with decreases in alpha 2A/D-adrenoceptor messenger RNA. Neuroscience 1997, 81:593-597.
34. Karkanias G.B., Morales J.C., Etgen A.M. Effects of diabetes and estradiol on norepinephrine release in female rat hypothalamus, preoptic area and cortex. Neuroendocrinology 1998, 68:30-36.
35. Kirby L.G., Kreiss D.S., Singh A., Lucki I. Effect of destruction of serotonin neurons on basal and fenfluramine-induced serotonin release in striatum. Synapse 1995, 20:99-105.
36. Kirby L.G., Lucki I. Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat. J Pharmacol Exp Ther 1997, 282:967-976.
37. Kõiv K., Zobel R., Raudkivi K., Kivastik T., Harro J. The effect of denervation of the locus coeruleus projections with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on cocaine-induced locomotion and place preference in rats. Behav Brain Res 2011, 216:172-179.
38. Lähdesmäki J., Sallinen J., MacDonald E., Sirviö J., Scheinin M. Alpha2-adrenergic drug effects on brain monoamines, locomotion, and body temperature are largely abolished in mice lacking the alpha2A-adrenoceptor subtype. Neuropsychopharmacology 2003, 44:882-892.
39. López-Rubalcva C, Mostalac-Preciado C, Estrada-Camarena E (2009). The rat forced swimming test: an animal model for the study of the antidepressant drugs. In: Models of neuropharmacology, (Rocha L, Granados V, eds). Kenin, India: Transworld Res Network.
40. López-Rubalcava C., Vega-Rivera N.M., Páez-Martínez N., Estrada-Camarena E. Participation of the monoaminergic system in the antidepressant-like actions of estrogens: a review in preclinical studies. Effects of antidepressants 2012, In Tech Open publications, ISBN: 979-953-307-524-1. pp. 47-72.
41. Lu N.Z., Eshleman A.J., Janowsky A., Bethea C.L. Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques. Mol Psychiatry 2003, 8:353-360.
42. Lubbers L.S., Zafian P.T., Gautreaux C., Gordon M., Alves S.E., Correa L., Lorrain D.S., Hickey G.J., Luine V. Estrogen receptor (ER) subtype agonists alter monoamine levels in the female rat brain. J Steroid Biochem Mol Biol 2010, 122:310-317.
43. Merz C.N., Olson M.B., McClure C., Yu-Ching Yang, Symons J., Sopko G., Kelsey S.F., Handberg E., Johnson B.D., Cooper-DeHoff R.M., Sharaf B., Rogers W.J., Pepine C.J. A randomized controlled trial of low dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health - National Heart, Lung, and Blood Institute (NHLBI) - sponsored Women's Ischemia Syndrome Evaluation (WISE). Am Heart J 2010, 159:987.e1-987.e7.
44. Mikail H.G., Dalla C., Kokras N., Kafetzopoulos V., Papadopoulou-Daifoti Z. Sertraline behavioral response associates closer and dose-dependently with cortical rather than hippocampal serotonergic activity in the rat forced swim stress. Physiol Behav 2012, 107:201-206.
45. Mongeau R., Blier P., de Montigny C. The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Res Brain Res Rev 1997, 23:145-195.
46. Moreno F., Parkinson D., Palmer C., Castro L., Misiaszek J., El Khoury A., Mathé A.A., Wright R., Delgado P.L. CSF neurochemicals during tryptophan depletion in individuals with remitted depression and healthy controls. Eur Neuropsychopharmacol 2010, 20:18-24.
47. Mostalac-Preciado C.R., de Gortari P., Lopez-Rubalcava C. Antidepressant-like effects of mineralocorticoid but not glucocorticoid antagonists in the lateral septum: interactions with the serotonergic system. Behav Brain Res 2011, 223:88-98.
48. Osterlund M.K. Underlying mechanisms mediating the antidepressant effects of estrogens. Biochim Biophys Acta 2010, 1800:1136-1144.
49. Page M.E., Detke M.J., Dalvi A., Kirby L.G., Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl) 1999, 147:162-167.
50. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego, CA. 4th ed.
51. Parry B.L. Perimenopausal depression. Am J Psychiatry 2008, 165:23-27.
52. Pecins-Thompson M., Brown N.A., Bethea C.L. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Mol Brain Res 1998, 53:120-129.
53. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977, 229:327-336.
54. Raap D.K., DonCarlos L., Garcia F., Muma N.A., Wolf W.A., Battaglia G., Van de Kar L.D. Estrogen desensitizes 5-HT(1A) receptors and reduces levels of G(z), G(i1) and G(i3) proteins in the hypothalamus. Neuropharmacology 2000, 39:1823-1832.
55. Rénéric and Lucki Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology (Berl) 1998, 136:190-197.
56. Revankar C.M., Cimino F.D., Sklar L.A., Arterburn J.B., Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-16030.
57. Rocha B.A., Fleischer R., Schaeffer J.M., Rohrer S.P., Hickey G.J. 17 Beta-estradiol-induced antidepressant-like effect in the forced swim test is absent in estrogen receptor-beta knockout (BERKO) mice. Psychopharmacology (Berl) 2005, 179:637-643.
58. Ross S.B. Long-term effects of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurones in the rat brain and heart. Br J Pharmacol 1976, 58. 521-517.
59. Scheibner J., Trendelenburg A.-U., Hein L., Starke K. α2-Adrenoceptors modulating neuronal serotonin release: a study in α2-adrenoceptor subtype-deficient mice. Br J Pharmacol 2001, 132:925-933.
60. Schneider L.S., Small G.W., Hamilton S.H., Bystritsky A., Nemeroff C.B., Meyers B.S. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am J Geriatr Psychiatry 1997, 5:97-106.
61. Schlicker E., Gothert M. Interactions between the presynaptic α2-autoreceptor and presynaptic inhibitory heteroceptors on noradrenergic neurons. Brain Res Bull 1998, 47:129-132.
62. Serova L.I., Harris H.A., Maharjan S., Sabban E.L. Modulation of responses to stress by estradiol benzoate and selective estrogen receptor agonists. J Endocrinol 2010, 205:253-262.
63. Shackelford D.P., McConnaughey M.M., Iams S.G. The effects of estradiol and mestranol on alpha-adrenoceptors in select regions of the rat brain. Brain Res Bull 1988, 21:329-333.
64. Soares C.N., Poitras J.R., Prouty J. Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause. Drugs Aging 2003, 20:85-100.
65. Soares C.N., Arsenio H., Joffe H., Bankier B., Cassano P., Petrillo L.F., Cohen L.S. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. Menopause 2006, 13:780-786.
66. Thomas P., Pang Y., Filardo E.J., Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005, 146:624-632.
67. Van de Kar L.D., Li Q., Cabrera T.M., Brownfield M.S., Battaglia G. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons. J Pharmacol Exp Ther 1998, 286:256-262.
68. Wade G.N., Powers J.B., Blaustein J.D., Green D.E. ICI 182,780 antagonizes the effects of estradiol on estrous behavior and energy balance in Syrian hamsters. Am J Physiol 1993, 265:R1399-R1403.
69. Walf A.A., Ciriza I., Garcia-Segura L.M., Frye C.A. Antisense oligodeoxynucleotides for estrogen receptor-b and a attenuate estradiol's modulation of affective and sexual. Neuropsychopharmacology 2008, 33:431-440.
70. Xie T., Tong L., McLane M.W., Hatzidimitriou G., Yuan J., McCann U., Ricaurte G. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines. Neuropsychopharmacology 2006, 31:2639-2651.